BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monje M, Iwasaki A. The neurobiology of long COVID. Neuron 2022;110:3484-96. [PMID: 36288726 DOI: 10.1016/j.neuron.2022.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, Mota-Araujo HP, Colodeti LC, Araújo SMB, Froz GM, da Silva TN, Duarte LA, Salvio AL, Pires KL, Leon LAA, Vasconcelos CCF, Romão L, Savio LEB, Silva JL, da Costa R, Clarke JR, Da Poian AT, Alves-Leon SV, Passos GF, Figueiredo CP. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep 2023;42:112189. [PMID: 36857178 DOI: 10.1016/j.celrep.2023.112189] [Reference Citation Analysis]
2 McMillan RE, Wang E, Carlin AF, Coufal NG. Human microglial models to study host-virus interactions. Exp Neurol 2023;363:114375. [PMID: 36907350 DOI: 10.1016/j.expneurol.2023.114375] [Reference Citation Analysis]
3 Oner P, Yilmaz S, Doğan S. High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term. JPM 2023;13:503. [DOI: 10.3390/jpm13030503] [Reference Citation Analysis]
4 Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, Pardo CA, Choi A, Cho SM. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells 2023;12. [PMID: 36899952 DOI: 10.3390/cells12050816] [Reference Citation Analysis]
5 Dobrigna M, Poëa-guyon S, Rousseau V, Vincent A, Toutain A, Barnier J. The molecular basis of p21-activated kinase-associated neurodevelopmental disorders: From genotype to phenotype. Front Neurosci 2023;17. [DOI: 10.3389/fnins.2023.1123784] [Reference Citation Analysis]
6 Bauer L, van Riel D. Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity? mBio 2023;14:e0292022. [PMID: 36651750 DOI: 10.1128/mbio.02920-22] [Reference Citation Analysis]
7 Lanz TV, Robinson WH, Ho PP, Steinman L. Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials. Clin Transl Immunology 2023;12:e1438. [PMID: 36815946 DOI: 10.1002/cti2.1438] [Reference Citation Analysis]
8 Simonin Y. Neurobiology of long-COVID: Hypotheses and unanswered questions. Anaesth Crit Care Pain Med 2023;42:101201. [PMID: 36801258 DOI: 10.1016/j.accpm.2023.101201] [Reference Citation Analysis]
9 Yan MZ, Yang M, Lai CL. Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis and Management. Viruses 2023;15. [PMID: 36851746 DOI: 10.3390/v15020533] [Reference Citation Analysis]
10 Zhong Y, Huang J, Zhang W, Li S, Gao Y. Addressing psychosomatic issues after lifting the COVID-19 policy in China: A wake-up call. Asian J Psychiatr 2023;82:103517. [PMID: 36791610 DOI: 10.1016/j.ajp.2023.103517] [Reference Citation Analysis]
11 Maple PAC. COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections. Vaccines (Basel) 2023;11. [PMID: 36851110 DOI: 10.3390/vaccines11020232] [Reference Citation Analysis]
12 Tsilioni I, Theoharides TC. Recombinant SARS-CoV-2 Spike Protein and its Receptor Binding Domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on  human microglia cells.. [DOI: 10.21203/rs.3.rs-2394904/v1] [Reference Citation Analysis]
13 Zhang PP, He ZC, Yao XH, Tang R, Ma J, Luo T, Zhu C, Li TR, Liu X, Zhang D, Zhang S, Ping YF, Leng L, Bian XW. COVID-19-associated monocytic encephalitis (CAME): histological and proteomic evidence from autopsy. Signal Transduct Target Ther 2023;8:24. [PMID: 36609561 DOI: 10.1038/s41392-022-01291-6] [Reference Citation Analysis]
14 Gietl M, Burkert F, Seiwald S, Böhm A, Hofer S, Gostner JM, Piater T, Geisler S, Weiss G, Loeffler-ragg J, Sonnweber T, Tancevski I, Pizzini A, Sahanic S, Fuchs D, Bellmann-weiler R, Kurz K. Interferon-gamma Mediated Metabolic Pathways in Hospitalized Patients During Acute and Reconvalescent COVID-19. Int J�Tryptophan�Res 2023;16:117864692311542. [DOI: 10.1177/11786469231154244] [Reference Citation Analysis]
15 Khan M, Clijsters M, Choi S, Backaert W, Claerhout M, Couvreur F, Van Breda L, Bourgeois F, Speleman K, Klein S, Van Laethem J, Verstappen G, Dereli AS, Yoo SJ, Zhou H, Dan Do TN, Jochmans D, Laenen L, Debaveye Y, De Munter P, Gunst J, Jorissen M, Lagrou K, Meersseman P, Neyts J, Thal DR, Topsakal V, Vandenbriele C, Wauters J, Mombaerts P, Van Gerven L. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron 2022;110:3919-3935.e6. [PMID: 36446381 DOI: 10.1016/j.neuron.2022.11.007] [Reference Citation Analysis]